Henry Schein EBITDA 2010-2024 | HSIC

Henry Schein EBITDA for the quarter ending September 30, 2024 was $0.231B, a 14.13% decline year-over-year.

  • Henry Schein 2023 EBITDA was 0.89B, a 7.19% decline from 2022.
  • Henry Schein 2022 EBITDA was 0.959B, a 9.7% decline from 2021.
  • Henry Schein 2021 EBITDA was 1.062B, a 47.3% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Henry Schein EBITDA 2010-2024 | HSIC

  • Henry Schein 2023 EBITDA was 0.89B, a 7.19% decline from 2022.
  • Henry Schein 2022 EBITDA was 0.959B, a 9.7% decline from 2021.
  • Henry Schein 2021 EBITDA was 1.062B, a 47.3% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$78.2B
Becton Dickinson (BDX)$64.4B
Cardinal Health (CAH)$28.6B
West Pharmaceutical Services (WST)$22B
Labcorp (LH)$19.8B
Cooper (COO)$19.7B
Align Technology (ALGN)$16.6B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.8B
CONMED (CNMD)$2.2B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$170M
Pro-Dex (PDEX)$147M